摘要
目的通过分析传统及新型口服抗凝药的特点,探讨肺血栓栓塞症(PTE)的规范化、个体化抗凝治疗。方法回顾性分析3例病情特殊的PTE患者的临床资料,并进行相关文献复习。结果 3例患者分别为高血压、肾功能不全、房颤、亚临床甲状腺功能减退症、银屑病合并PTE,自身免疫性溶血性贫血合并PTE,肺隐球菌病合并PTE,分别给予利伐沙班、华法林、达比加群进行抗凝治疗,效果良好。结论 PTE患者行规范化、个体化抗凝治疗可提高存活率。
Objective To investigate the characteristics of 3 cases of pulmonary thromboembolism（PTE） and to explore the factors of thrombosis and treatments with standardization and individualization.Methods Clinical data of 3 special cases of PTE were analyzed retrospectively and relevant literature were reviewed.Results Three patients have different special complications,including high blood pressure,renal insufficiency,atrial fibrillation,subclinical hypothyroidism,psoriasis combined PTE,autoimmune hemolytic anemia combined PTE,pulmonary cryptococcosis combined PTE,patients were given oral anticoagulant drugs included rivaroxaban,warfarin and dabigatran etexilate capsules,3 cases were cured.Conclusion Individualized and rationalized treatment in PTE patients can improve survival rate.
作者
林莹
李彦华
郭新红
徐勇
李玉峰
刘昱圻
LIN Ying LI Yan-hua GUO Xin-hong XU Yong LI Yu-feng LIU Yu-qi(Department of Cardiovascular, Chinese PLA General Hospital, Beijing 100853, China)
出处
《创伤与急危重病医学》
2017年第1期54-57,共4页
Trauma and Critical Care Medicine
关键词
肺血栓栓塞症
肺栓塞
新型口服抗凝药
抗凝治疗
Pulmonary thromboembolism
Pulmonary embolism
New oral anticoagulants
Anticoagulation therapy
